PDCD1 and neoplasm: Vaccination with mRNA vaccine encoding shared MMRd neoantigens + anti-PD1 in the presence of a WT tumor on one flank and a MMRd tumor on the other flank resulted in reduced growth of the WT tumor in the presence of either anti-PD-1 +/− vaccination (Figure 3 F).